This Biotech Stock was Once a Penny Stock but is Now Making Big Moves on the Nasdaq!

This former penny stock now a full fledged Nasdaq Biotech Stock deserves your attention & here’s why.

GT Biopharma Announces Positive Preclinical Results For GTB-5550 B7H3 TriKE™

POTENTIAL TREATMENT OF SEVERAL SOLID TUMOR CANCERS INCLUDING: NON-SMALL CELL LUNG CANCER,…